For: | Ray S, Palui R. Immunotherapy in type 1 diabetes: Novel pathway to the future ahead. World J Diabetes 2024; 15(10): 2022-2035 [PMID: 39493558 DOI: 10.4239/wjd.v15.i10.2022] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v15/i10/2022.htm |
Number | Citing Articles |
1 |
Eugenio Cavalli, Giuseppe Rosario Pietro Nicoletti, Ferdinando Nicoletti. Historically Based Perspective on the Immunotherapy of Type 1 Diabetes: Where We Have Been, Where We Are, and Where We May Go. Journal of Clinical Medicine 2025; 14(16): 5621 doi: 10.3390/jcm14165621
|
2 |
Rui Wei, Bochao Jia, Shuang Zheng, Xuexue Zhang, Miaoran Wang, Ning Sun, Rui Zhang, Qiuyan Li. Application of monoclonal antibodies in diabetes: A bibliometric analysis from 2004–2024. Human Vaccines & Immunotherapeutics 2025; 21(1) doi: 10.1080/21645515.2025.2536910
|
3 |
Yazdan Ebrahimpour, Sahbasadat Khatami, Mahsa Saffar, Alireza Fereidouni, Zahra Biniaz, Nafiseh Erfanian, Mohammad Fereidouni. A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus. Journal of Diabetes 2025; 17(8) doi: 10.1111/1753-0407.70120
|
4 |
Rahul Mittal, Vedaant Mutha, Eavin A. Valerio, Krish Hirani, Giuliana Arevalo, Ayushi Panchal, Mannat Mittal, Joana RN Lemos, Khemraj Hirani. Emerging role of gene therapy in immune modulation and beta-cell preservation in Type 1 diabetes. Journal of Drug Targeting 2025; : 1 doi: 10.1080/1061186X.2025.2522869
|